| 1 |
26264927 | PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier. | 2015 Nov |
1 |
| 2 |
24011632 | Pharmacokinetic and pharmacodynamic study of Gefitinib in a mouse model of non-small-cell lung carcinoma with brain metastasis. | 2013 Nov |
3 |
| 3 |
20421331 | Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux. | 2010 Jul |
5 |
| 4 |
19324269 | In vivo evaluation of P-glycoprotein and breast cancer resistance protein modulation in the brain using [(11)C]gefitinib. | 2009 Apr |
5 |
| 5 |
19567673 | Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid. | 2009 Jul 15 |
1 |
| 6 |
16686369 | Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse. | 2006 Jan-Feb |
1 |